Psychedelic Health

22/09/2025

Go beyond the hype at the Borealis Psychedelic Science Summit.

As a partner of Borealis Psychedelic Science Summit 2025, PSYCH Symposium is happy to offer a 15% discount to our community. Use the code PSYCH15 to get your tickets.

The Swedish Network for Psychedelic Science will host a two-day scientific conference in Stockholm, aimed at advancing the discourse on psychedelic science and therapy. With engaging talks, interactive workshops, and invaluable networking opportunities, the Borealis Psychedelic Science Summit will be the premier summit on psychedelic science in Europe this year.

WHEN: September 26-27th, 2025
WHERE: Elite Hotel Marina Tower, Stockholm
TICKETS & INFO: https://borealissummit.com/

19/09/2025

📢 The Royal College of Psychiatrists has released its first comprehensive position on psychedelics.
The report recognises their promise for conditions like depression and PTSD but stresses that stronger evidence is needed before routine use.
With calls for rigorous trials, safety monitoring and ethical oversight, this marks an important step toward integrating innovative treatments into mental health care.

👉 Read more:

On Friday, the Royal College of Psychiatrists has published a new report assessing the safety and efficacy of psychedelics and related substances as treatments for mental illness. The College, which is the main professional organisation for psychiatrists in the United Kingdom, also issued guidance f...

16/09/2025

📢 PSYCHEDELICS EXPERTS WANTED 📢
Psychedelic Health is on the lookout for leading voices to contribute to our new opinion column! ✏️

✍️ As part of our commitment to amplifying diverse perspectives in the psychedelics ecosystem, we’re proud to launch a new op-ed program featuring articles from experts across the field.

If you believe your voice should be heard, send your ideas to [email protected]

💡 We’re looking to showcase thought leaders in science, policy, industry, and culture: all within the context of psychedelic healthcare.

13/09/2025

🌟 Big news in psychedelic medicine! A new study shows that a single dose of L*D (MindMed’s MM120) can provide lasting relief for generalized anxiety disorder.

This marks the first randomized, placebo-controlled trial of L*D for anxiety in decades. MindMed is now moving forward with Phase 3 trials, aiming to bring this potential treatment closer to patients.

While MM120 is not yet approved, these results renew hope for new approaches to anxiety treatment.

Read the full story: https://psychedelichealth.co.uk/2025/09/13/new-clinical-trial-shows-lsd-can-improve-anxiety-symptoms/

*D

12/09/2025

As a community partner for Global Psychedelic Week, we're happy to offer a free ticket for the upcoming seven-day international event celebrating psychedelic science, culture, therapy, and community. November 3–9, 2025.
The first person to comment on this post will get the free ticket!

04/09/2025

Are psychedelic “trips” essential for healing, or just a side effect?

A recent article by Albert Garcia-Romeu, PhD explores how substances like ketamine, M**A, psilocybin, and L*D shape perception, emotion, and self-awareness. While these experiences can predict some therapeutic benefits biology may play an even bigger role.

From boosting brain plasticity to reducing inflammation, scientists are uncovering pathways to healing that may not require hallucinations at all.

With new compounds in development, the future of psychedelic therapy may look very different.

👉 Read more:

A new article published in Nature by Dr. Albert Garcia-Romeu, Associate Professor at Johns Hopkins University, looks at whether the mind-bending, hallucinogenic experiences from psychedelics truly underpin their mental health benefits. Psychedelic substances such as psilocybin and L*D are known for....